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Abstract Podocytes are highly specialized epithelial cells
localized in the kidney glomerulus. The distinct cell signaling
events and unique cytoskeletal architecture tailor podocytes to
withstand changes in hydrostatic pressure during glomerular
filtration. Alteration of glomerular filtration leads to kidney
disease and frequently manifests with proteinuria. It has been
increasingly recognized that cell signaling and cytoskeletal
dynamics are coupled more tightly to membrane trafficking
than previously thought. Membrane trafficking coordinates
the cross-talk between protein networks and signaling cas-
cades in a spatially and temporally organized fashion and may
be viewed as a communication highway between the cell
exterior and interior. Membrane trafficking involves transport
of cargo from the plasma membrane to the cell interior (i.e.,
endocytosis) followed by cargo trafficking to lysosomes for
degradation or to the plasma membrane for recycling. Yet,
recent studies indicate that the conventional classification
does not fully reflect the complex and versatile nature of
membrane trafficking. While the increasing complexity of
elaborate protein scaffolds and signaling cascades is being
recognized in podocytes, the role of membrane trafficking is
less well understood. This review will focus on the role of
membrane trafficking in podocyte health and disease.
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Membrane trafficking
All living cells process information by trafficking cargo,
such as extracellular ligands, microorganisms, nutrients,
transmembrane proteins and lipids from the plasma mem-
brane to endocytic vesicles (i.e., endocytosis). A reciprocal
process called recycling balances endocytosis and returns
much of the internalized membrane and cargo to the cell
surface. The balance between endocytosis and recycling
controls the plasma membrane composition and provides
cells with information that has been resolved in time and
space. A wealth of new evidence is uncovering the role of
endocytosis and recycling as master regulators of diverse
cellular functions such as nutrient uptake and metabolism,
development, proliferation, differentiation and polarity,
reprogramming, migration, cell adhesion and migration,
cytokinesis, and neurotransmission [1–3]. Endocytic and
recycling pathways are very dynamic and highly coordinat-
ed and allow cells to turn over an equivalent of the entire
plasma membrane one to five times per hour. Such dynamic
organization of membrane trafficking requires diverse pro-
tein networks, including the Bin/Amphiphysin/Rvs (BAR)
superfamily of proteins, guanine triphosphate hydrolases
(GTPases), non-conventional progressive motors, cytoskel-
etal proteins and their regulators, cell adhesion and sorting
molecules, channels, members of the ubiquitin pathway, and
lipids [1, 4]. Although endocytosis and recycling are ubiq-
uitous, specific trafficking itineraries are cell- and cargo-
specific and depend on the state of cell polarization. Endo-
cytic trafficking can be constitutive and/or ligand activated.
Alterations of membrane trafficking can manifest as con-
genital syndromes and malformations, cancer, inflamma-
tion, and immunodeficiency [1].
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Mechanisms of endocytic entry
Endocytosis occurs by various mechanisms that can be
broadly divided into clathrin-dependent and clathrin-
independent (Table 1). The clathrin-dependent endocytosis
(CDE) is one of the most important internalization routes in
eukaryotic cells [1]. In CDE, endocytic adaptors recognize
linear internalization sequences located in the intracellular
C-terminal domains of membrane proteins destined for en-
docytosis and recruit these proteins as cargo at membrane
domains engulfed on the cytosolic side with clathrin lattices
called clathrin-coated pits (CCPs). Subsequently, additional
adaptors cleave off CCPs at the neck and release them into
the cell interior as clathrin-coated vesicles (CCVs). Clathrin-
independent endocytosis (CIE) encompasses a diverse
group of internalization mechanisms sharing a common
requirement for free cholesterol, proteins, and lipids that
reside in sphingolipid-rich lipid raft membranes [5]. Collec-
tively, CIE may account for as much as 50 % of the total
endocytic activity in a cell (Table 1).
Membrane remodeling and vesicle severing
Remodeling of the plasma membrane at the onset of endo-
cytosis starts with the formation of functional nanoscopic
domains and leads to local membrane deformation and
curvature change [4]. The BAR domain proteins recognize
changes in membrane curvature, facilitate interactions be-
tween the plasma membrane and endocytic adaptors, and
lead to membrane invagination directed towards the cell
interior. Similarly, endophilins A1-3 sense and bend plasma
membranes to form CCPs (see below). For most, but not all
of the endocytic entry mechanisms, the large GTPase, dyna-
min cleaves off the budded vesicles at the neck and releases
them into the cell interior.
Endocytic compartments
Regardless of the mechanism of endocytosis, internalized
cargo is transported to early endosomes (EE), the focal point
of the endocytic pathway. EEs comprise functionally and mor-
phologically heterogenous vesicular membranes consisting of
distinct sub-domains such as the multi-vesicular region with
large intraluminal vesicles (300–400 nm) and tubular exten-
sions (60–80 nm diameter) [4]. EEs sort internalized cargo to
several destinations, either late endosomes (LE) followed by
traffic to lysosomes for degradation or the trans-Golgi network
(TGN) or recycling endosomes (RE) for recycling to the plasma
membrane. Several hypotheses have been proposed to explain
how cargo is sorted from EEs to subsequent destinations. The
Table 1 Mechanisms of endocytosis
Pathway Morphology
and size
Coat Small GTPase Cargo Function
Clathrin-mediateda Vesicular
150–200 nm
Clathrin Rab5 RTKs, GPCR, TGF-ßR, Notch, TfR,
LDLR, ß-arrestin, Wnt/ß-catenin





Unclear GPI-APs, TGF-ßR, CTxB,
viruses, folic acid, IGF-1R,
Wnt/ß-catenin
Cell signaling, lipid regulation,
vesicular transport, transcytosis
CLIC/GEEC Tubular None Cdc42 Arf1 GPI-APs, glycosphingolipids,
cholera toxin




Arf6-mediated Tubular None Arf6 ß-arrestins, MHC I-II Membrane curvature
Flotillin-mediated Vesicular Flotillin
1 and 2
None CTxB, GPI-AP, proteoglycans Lipid raft-mediated endocytosis,
IL-2Ra Vesicular
50–100 nm
None RhoA, Rac1 IL-2Rß, yc cytokine receptor IL-2R endocytosis and signaling
Macropinocytosisa Ruffled None Rac1, Cdc42,
Arf6, Rab5
Fluid, RTKs, bacteria Extracellular fluid uptake, actin dynamics
Phagocytosis Cargo shaped None Rac1, RhoA,
Cdc42
Nutrients, pathogens, dead
cells, and cellular debris
Uptake of nutrients, pathogens, and cellular
debris by professional phagocytic cells;
opsonization of foreign particles
followed by actin rearrangements
Arf, ADP rybosylation factor; GTPase, guanine triphosphate hydrolyze; Cdc42, cell division control protein 42 homolog; CLIC, clathrin-
independent carriers; CTxB, cholera toxin B subunit; GEEC, GPI-AP-enriched early endosomal compartment; GPI-APs, glycosphingolipids
anchored proteins; GPCR, G-protein coupled receptor; Rab, ras-associated binding protein; IGF-1R, insulin growth factor-1 receptor; IL-2R,
interleukin 2 receptor beta; TRKs, receptor tyrosine kinases; TfR, transferring receptor; LDLR, low-density lipoprotein receptor; MHC, Major
histocompatibility complex; RhoA, Ras homolog gene family, member A; Rac1, Ras-related C3 botulinum toxin substrate 1; TGF-ßR, transforming
growth factor beta receptor
a marks the dynamin-dependent mechanisms; macropinocytosis requires dynamin only in some situations. The above information is based on
references listed in this manuscript (most extensively reviewed in refs. [1, 2]. Only selected cargo and functions are listed
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prevailing view is that sorting is achieved through recruitment
of specific adaptors synchronized with changes in the local pH
and clustering of cargo in the EE sub-domains followed by
morphological changes in the EE membranes to release the
specialized cargo containing vesicles [4]. Cargo targeted for
degradation clusters in the multi-vesicular region of EEs where
the pH decreases from 6.2 to ~5.5 and is subsequently released
into multivesicular bodies (MVB) that become LEs and ulti-
mately lysosomes. By contrast, cargo targeted for recycling
clusters in the tubular extensions of EEs where the pH rises to
~6.5.
The EE membranes are characterized by presence of nu-
merous protein adaptors [6]. The small GTPases, Ras-
associated binding (Rab) proteins play a critical role in or-
chestrating cargo sorting. Rabs cycle between the active or
GTP bound, membrane-associated state and the inactive or
GDP bound, soluble state. The changes in Rab activity are
coupled to the reversible association with target membranes.
In the active (i.e., membrane bound) state, Rabs recruit diverse
effectors to the target vesicles and together control cargo
selection, vesicle budding and tethering, and membrane fu-
sion. Rab5 is enriched in EEs.
Recycling mechanisms
By way of EE tubulation and acquisition of specific adaptors
luminal cargo can be recycled back to the plasma membrane
via the fast (t1/205 min) and slow (t1/2015–30 min) recy-
cling pathways [7]. For classic CDE cargo such as the trans-
ferrin receptor (TfR) and low-density lipoprotein (LDL)
receptor, the fast recycling pathway is considered a default
route not requiring sequence motifs for recognition and sort-
ing. During fast recycling, TfR is sorted to the Rab4 and away
from the Rab5 microdomain on the same vesicle [8]. Al-
though Rab4 has an established role in the fast recycling
pathway, its precise role has not been established as studies
demonstrate that expression of the GDP locked, dominant
interfering Rab4 mutant inhibits fast recycling while Rab4
depletion increases rapid recycling, perhaps by blocking traf-
ficking via the slow recycling pathway [8]. Recent studies
have focused on the role of Rab35 (also known as receptor-
mediated endocytosis or RME-5) as an important regulator of
fast recycling [9]. Rab35 localizes to the plasma membrane
and EEs and is required for fast recycling of TfR. Recruited of
Rab35 to CCPs suggests that it plays a role in fast recycling of
the CDE cargo. Moreover, association of Rab35 with the ADP
rybosylation factor 6 (Arf6)-positive tubular REs suggests that
Rab35 may also play a role in fast recycling of the CIE cargo.
Alternatively, cargo, including TfR can be sorted from EEs
to the juxtanuclear endocytic recycling compartment (ERC)
via the slow recycling pathway. This pathway is usually
studied when experimentally measuring recycling and
involves trafficking from the EEs to ERC and from the ERC
to the plasma membrane. ERC is a tubular compartment
devoid of fluid and is defined by presence of either Rab11 or
EHD1 (RME-1 family of carboxy-terminal epidermal growth
factor receptor substrate 15 (EPS15) homology domain con-
taining protein 1)) or both [10]. EHD1 is scaffolding, mem-
brane tabulating, and possibly membrane fission protein and
an important regulator of recycling out of the ERC. Sorting
nexins direct cargo from the EEs to ERC while preventing
entry into the degradative compartment [11]. Recycling from
the ERC to plasma membrane occurs in via two distinct
compartments. Although both require Rab11, the REs utilized
for TfR trafficking differ from the tubular REs that carry the
CIE cargo internalized back to the plasma membrane. The
previously held view that cargo lacking the biosynthetic of
degradative signals is sorted for recycling in the ERC has been
challenged by identification of sorting motifs for recycling,
unlike in the fast recycling route, where recycling sequence
motifs are considered unnecessary [12].
Lysosomal targeting
Trafficking of cargo destined for lysosomal degradation
requires signals for recruitment of the sorting machinery
[13]. Ubiquitination (i.e., attachment of ubiquitin molecules
to lysine residues on target proteins) serves as such signal [14].
Ubiquitinated cargo is recognized in EEs by hepatocyte
growth factor regulated tyrosine kinase substrate (Hrs) via its
ubiquitin interacting motif (UIM). Hrs also interacts with the
multi-vesicular region of the EEs involved in cargo sorting for
degradation and away from tubule forming, recycling mem-
branes. Two additional UIM containing proteins, epidermal
growth factor receptor substrate 15 (Eps15) and signal trans-
ducing adaptor molecule 2 (STAM2) stabilize the association
of Hrs with the ubiquitinated cargo and form a functional
sorting complex. Subsequent binding of Hrs to the tumor
susceptibility gene 101 (Tsg101) subunit of the endosomal
sorting complex required for transport (ESCRT-I) recruits the
ubiquitinated cargo complex to LEs. Assembly of ESCRT
complexes leads to formation of MVBs, lysosomal fusion,
and cargo degradation.
Transcytosis
Polarized epithelial cells require protein delivery to apical or
basolateral membranes. Many proteins reach their final des-
tination via direct vectorial transport from the TGN. By
contrast, other proteins, initially delivered to one membrane
domain are subsequently endocytosed and redirected to the
ultimate domain via transcytosis [15]. Transcytosis requires
post-endocytic entry into a specialized recycling route, in
which proteins are destined for recycling to the ultimate
membrane domain or transport to lysosomes. Although
presence of transcytosis has been well established, its
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functional importance varies in different cell types and its
role in overall epithelial polarity is inconclusive.
Membrane trafficking and cell signaling
Membrane trafficking coordinates signaling by directing
ligands, receptors, and effectors at a precise time to specific
microdomains where signaling is required [1, 2]. In this man-
ner, membrane trafficking may initiate or stop and accelerate
or attenuate signaling by engaging or disengaging signaling
cascades in vesicular compartments. Specifically, membrane
trafficking may regulate net signaling output: (a) by control-
ling accessibility of ligands, receptors, and accessory proteins
at the plasma membrane; (b) by targeting ligand-receptor
complexes to different endocytic routes; (c) by sorting inter-
nalized ligand-receptor complexes for either recycling or deg-
radation; and (d) by recruiting different signaling pathways to
the same vesicular compartment to orchestrate cross-talk.
Podocytes
The kidney glomerulus is a filtering apparatus allowing pas-
sage of water and solute into the urinary space while retaining
the vast majority of plasma proteins within the circulation.
Podocytes together with the glomerular basement membrane
(GBM) and fenestrated capillary endothelial cells form a
morphological and functional unit called the glomerular fil-
tration barrier (GFB) [16]. Although, the precise mechanism
of GFB selectivity is still a matter of debate, the cross-talk
between components of the GFB and the subpodocyte space
determines glomerular filtration characteristics [16]. The ma-
ture podocyte consists of the cell body, the microtubule and
intermediate filament-based primary and secondary processes,
and actin-based tertiary or foot processes (FP). Resting on the
GBM, FPs form interdigitating extensions linked by the glo-
merular slit diaphragm (GSD), which provides the only cell-
cell contact between mature podocytes [17]. The develop-
ment, differentiation, and maintenance of mature podocytes
require temporally and spatially coordinated activation of
various protein networks and signaling cascades. Our current
understanding of role and mechanisms of membrane traffick-
ing in these aspects of podocyte biology are reviewed below.
Membrane trafficking during podocyte development
and differentiation
Kidney development is a process of morphogenesis and
patterning that eventually leads to formation of highly spe-
cialized cells tailored to perform unique functions [18]. Four
stages characterize glomerulogenesis of mammalian kidneys
[18]. During the first stage the renal vesicle appears—the
primordial epithelial structure that originates from the cap
mesenchyme. During the second stage the comma-shaped
body forms, followed by the S-shaped body that subse-
quently gives rise to the precursors of podocyte and renal
tubules. The glomerular capillary system appears during the
third stage and glomerular maturation occurs during the
fourth stage.
Formation of the renal vesicle from the cap mesenchyme
during the first stage of glomerulogenesis is initiated by
induction of undifferentiated mesenchyme by signals from
the ureteric bud (UB) to undergo mesenchymal-epithelial
transition (MET) [19]. An array of factors and receptors
mediate MET in a manner highly coordinated in regards to
time and space. Wnt/ß-catenin and transforming growth
factor ß (TGF-ß) signaling pathways regulate MET during
glomerulogenesis [20]. The Wingless-type mouse mammary
tumor virus integration site family, member 4 (Wnt4) ligand
is necessary and sufficient for MET during glomerulogene-
sis and is regulated by the Wilms’ tumor suppressor-1
(WT1) transcription factor [21]. Wnt ligands bind to frizzled
receptor and the LDL 5 or 6 coreceptor to destabilize the ß-
catenin destruction complex [2]. The Wnt/ß-catenin signal-
ing utilizes two endocytic routes, CDE and caveolae-
mediated CIE [2]. While CIE activates, CDE inhibits Wnt/
ß-catenin signaling [1]. Similarly, the TGF-ß receptor com-
plex (TGF-ßR) exploits both CDE and caveolae-mediated
CIE. However, unlike Wnt/ß-catenin, TGF-ß signaling is
activated by CDE and terminated by CIE (at least in some
cases; Table 1). The TGF-ß pathway directs the action of
Wnt during MET and it is plausible that both pathways
converge in endocytic vesicles during signaling. Mesenchy-
mal induction is also regulated by epidermal growth factor
(EGF) and fibroblast growth factor (FGF) receptors and
membrane trafficking is critical for their signaling [1].
Podocyte formation occurs during the second stage of
glomerulogenesis, when the proximal segment of the S-
shaped body differentiates to form the parietal (Bowman
capsule) and the visceral (podocytes) epithelium [18]. Notch
signaling controls segmentation of the comma-shaped body
and generation of the S-shaped body, which further differ-
entiates to form podocytes [22]. Signal transduction is initi-
ated by engagement of the plasma membrane Notch
receptors expressed on the signal-receiving cells with
ligands anchored at the plasma membrane on signal-
sending cells. Membrane trafficking is critical for spatial
and temporal regulation of Notch signaling and involves
CDE and CIE [1, 2]. CDE facilitates unfolding and prote-
olysis of the Notch receptor essential for its activation.
Moreover, endocytosis and recycling recruit ligands to re-
stricted regions of the plasma membrane and promote high
local ligand abundance resulting in robust Notch activation
[23]. To date, membrane trafficking has not been studied in
Notch signaling during podocyte development. These stud-
ies could increase our understanding of temporal and spatial
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regulation of podocyte development. Moreover, examining
the dynamic regulation of Notch signaling by membrane
trafficking could resolve some differences observed in the
role of Notch in podocyte development [24, 25].
Semaphorin3a (Sema3a) is another signaling molecule re-
cently shown to play a crucial role in podocyte differentiation
in vivo where tight regulation of Sema3a signaling is essential
for developing normal GFB [26]. The mechanism whereby
Sema3a signaling is controlled during glomerulogenesis
remains unknown. However, based on recent data, it can be
hypothesized that control of Sema3a signaling is mediated by
expression of transcription factors that regulate rates of
flotillin-mediated CIE of Sema3a receptors [27]. It remains
to be determined whether flotillin-mediated CIE coordinates
Sema3a signaling during glomerulogenesis.
Membrane trafficking during podocyte maturation
Epithelial cell maturation involves polarized (i.e., asymmet-
ric) distribution of signaling molecules and cytoskeletal
components that subsequently organize growth of distinct
cellular structures. Podocyte maturation leads to asymmetric
distribution of protein complexes in specialized membrane
domains that allow contact between FPs via GSDs and
between FPs and the GBM via focal contacts (FC). To
acquire polarized podocyte organization, primordial colum-
nar epithelial cells lose some of the typical epithelial char-
acteristics, such as expression of cytokeratin and
desmosomal proteins and regain de novo some mesenchy-
mal features, such as expression of the intermediate filament
protein, vimentin [28]. Ultimately, the mature podocyte
become organized as an arborized structure defined by the
unique architecture and contractile apparatus. The GSD
forms during podocyte maturation when the apical junction-
al complex (AJC) of primordial columnar epithelium
migrates laterally from apex to base. After migration of
AJCs the podocyte cell body extends apically towards Bow-
man’s capsule and FPs develop at the basal pole. Although
there is little direct evidence from maturing podocytes,
studies in other model systems demonstrate that endocytosis
and recycling facilitate migration of AJCs along the lateral
membrane by organizing disassembly of the old and assem-
bly of the new junctional complexes [29].
Much insight into the role of membrane trafficking in
breaking the symmetry that takes place during cell polari-
zation has been learned from studying budding yeast. It has
been demonstrated that three trafficking events are sufficient
to achieve and maintain the asymmetric distribution of pro-
teins that initiate and maintain cell polarization [30]. First,
proteins are transported in vesicles from the cytoplasm to
the plasma membrane along the actin and microtubule fila-
ments referred to as directed transport. Second, proteins
inserted into the plasma membrane cluster in micro-
domains via two-dimensional diffusion. Third, proteins un-
dergo a turnover between the cell membrane and interior by
endocytosis and recycling. The rates and feedbacks from the
trafficking events and the cross-talk between trafficking and
the actin and microtubule cytoskeleton are sufficient to
determine the shape of polarized distribution, the strength
of polarization, and ultimately the morphogenic fate [31].
Several protein complexes are known to initiate and
maintain cell polarization. The Rho GTPase, cell division
control protein 42 homolog (Cdc42) is the prototypical
protein required for polarization, recently confirmed to play
a critical role in podocyte polarization [32]. The evolution-
arily conserved polarity complexes, Crumbs and Scribble
control apical and basolateral polarity, respectively and both
play a role in podocyte maturation [33]. The tight junction
(TJ)-associated partitioning defective (PAR), Par3/Par6/ac-
tivated protein kinase C (aPKC) polarization complex is
essential in establishing and maintaining polarity by facili-
tating asymmetric targeting of proteins that maintain func-
tional differences between the apical and basolateral
membrane [34]. Par3/Par6/aPKC is essential for podocyte
polarization and maintenance of GSD function [35]. In
response to polarization signals in podocyte precursors,
Par3/Par6/aPKC complexes migrate the apicolateral AJCs
towards the basolateral location through mechanisms de-
scribed above, namely directed transport, two-dimensional
diffusion and endocytic recycling until assuming the ulti-
mate location of the GSD [36, 37].
Membrane trafficking at the glomerular slit diaphragm
(GSD)
Despite retaining some features of the AJC, namely the TJ
and adherence junction (AJ), the mature GSD has unique
composition and architecture consisting of membrane bridg-
ing protein networks and juxtaposed cytoplasmic protein
complexes that interact with the actin cytoskeleton [38].
The GSD maintains selective permeability between the
blood and urinary space (gate function), separates the apical
and basolateral plasma membrane (fence function), and
serves as a signaling platform (signaling function). While
ultrastructural observations of the AJC and GSD convey an
image of a static structure, overwhelming evidence demon-
strates that dynamic remodeling by membrane trafficking is
essential for the fence, gate and signaling function [39, 40].
Nephrin, a transmembrane protein critical for the GSD
function belongs to the immunoglobulin superfamily of cell
adhesion molecules (IgCAM) [41]. The extracellular
domains of nephrin molecules expressed between adjacent
FPs form homophilic interactions [42]. The dynamic model
of the GSD as well as the pathophysiological, morphologi-
cal, and biochemical changes resulting from absence or
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mislocalization of nephrin predict that membrane trafficking
is vital to nephrin function [43, 44].
Nephrin localization at the GSD and its function is crit-
ically dependent on podocin, the integral membrane protein
localized at the GSD lipid raft domains [45]. Podocin gene
mutations associated with steroid resistant hereditary and
sporadic nephritic syndrome (NS) lead to nephrin mislocal-
ization because the mutant podocin is absent from the GSD
lipid rafts [45, 46]. Podocin belongs to a large family of
integral membrane proteins carrying an evolutionary con-
served prohibitin homology (PHB) domain—a primordial
lipid recognition motif [47]. While the molecular mecha-
nism of podocin-mediated nephrin recruitment to lipid rafts
is unknown, studies of other proteins containing the PHB
domain, namely flotillins shed some light. Flotillins tightly
associate with the inner leaflet of the plasmamembrane via the
PHB domain located near the N-terminus and via palmitoy-
lated and myristoylated domains upstream of the N-terminus
[48]. The PHB domain contains hydrophobic regions capable
of forming a hairpin that helps to insert the protein into the
plasma membrane inner leaflet. The predicted topology of
mouse podocin has intracellular N- and C-terminal domains,
a transmembrane domain, and C-terminally located PHB do-
main that, unlike the PHB of flotillins, is not involved in
hairpin formation [45]. Flotillins form homo- and heterophil-
lic interactions mediated via the C-terminal region conserved
only within the flotillin family while in podocin both the N-
and C-terminal domains were shown to mediate homooligo-
merization [45, 48]. As of now, nothing is known about the
hydrophobic stretches that form the hairpin in podocin and
whether podocin interactions with GSD lipid rafts involve
palmitoylation and/or myristoylation.
Flotillins orchestrate lipid raft-based signaling platforms
and flotillin-rich membranes that are critical for endocytosis
of several receptors, some of which require the Src family
kinase, Fyn [49]. Nephrin phosphorylation by Fyn augments
the interaction with podocin and facilitates nephrin CIE and
signaling [50, 51]. Nephrin was implicated to undergo CDE
and CIE [51–53]. Utilizing different endocytic itineraries by
a single receptor is a common phenomenon and serves to
diversify signaling specificity and strength [1]. Presence of
several putative tyrosine-based endocytic motifs in the cy-
toplasmic C-terminal tail of nephrin supports the notion that
nephrin may undergo CDE. While lipid raft-mediated CIE
is facilitated by nephrin phosphorylation and augments
nephrin signaling, CDE could play a role in attenuating
nephrin signaling. A prerequisite for CDE would be disso-
ciation of the nephrin–podocin complex followed by neph-
rin partitioning to non-raft membrane domains. Quack et al.
demonstrated that ß-arrestin mediates nephrin endocytosis
by a mechanism that requires dephosphorylation of the
Y1193 residue in the nephrin cytoplasmic tail [54]. By con-
trast, phosphorylation of the Y1193 residue by Fyn augments
nephrin interaction with podocin, prevents nephrin interac-
tion with ß-arrestin, and attenuates nephrin endocytosis
while augmenting nephrin signaling [54]. The mechanism
of ß-arrestin-mediated nephrin internalization in podocytes
is not completely understood. ß-arrestins are known to in-
teract predominantly with the CDE adaptors, clathrin and
the assembly polypeptide-2 complex (AP-2) but may also
interact with Arf6 in the CIE pathway [55, 56]. It can be
predicted that phosphorylation of Y1193 may inhibit CDE by
inactivating the Y1193-based endocytic motif in nephrin.
Y1193 and subsequent amino acid residues D-E-V in human
nephrin conform to a canonical, tyrosine-based endocytic
signal of the YxxØ type where the residues in position +1
and +2 are any amino acids, and +3 is a bulky amino acid
with a hydrophobic side chain. The phosphorylation state of
the Y residue in the YxxØ sequence serves as a regulatory
switch that determines whether the protein is retained or
removed from the plasma membrane by endocytosis [57].
Phosphorylation of the Y residue inhibits the interaction of
YxxØ with the μ2 subunit of AP-2 and prevents endocytosis.
By contrast, dephosphorylation of the Y residue allows the
YxxØ to interact with AP-2 and facilitates endocytosis.
According to this model, ß-arrestin would sequester nephrin
from interacting with podocin in lipid rafts, and would prevent
Fyn-mediated phosphorylation of Y1193 allowing nephrin to
undergo CDE. ß-arrestin is also known to utilize ubiquitina-
tion as means of receptor downregulation and degradation
[56]. Thus, dephosphorylation of Y1193 could serve as an
alternative or additional mechanism of nephrin endocytosis
by ubiquitination. Adding another level of complexity,
ß-arrestin was reported to scaffold Src kinases [56]. In view
of this finding it is difficult to reconcile how ß-arrestin would
prevent phosphorylation of Y1193 by Fyn.
PKC-α induces nephrin endocytosis and leads to protein-
uria and the loss of PKC-α prevents nephrin depletion in
diabetic nephropathy [58, 59]. Interestingly, PKC-α phos-
phorylates T1120 and T1125 residues in the nephrin intracel-
lular domain and facilitates nephrin interaction with ß-
arrestin in murine podocytes implicating that PKC-α may
regulate nephrin endocytosis [52]. Even though nephrin
abundance in the plasma membrane of transiently trans-
fected fibroblasts was increased by the dominant negative
dynamin and Eps15, implicating that nephrin undergoes
CDE in these cells and it was decreased by high glucose
that stimulates PKC-α the specific mechanism of ß-arrestin-
mediated nephrin endocytosis in podocytes remains to be
determined. ß-arrestin determines postendocytic itineraries
of several receptors. Following CDE, receptors are trans-
ported either to the fast or slow recycling route, depending
on the stability of interaction between the receptor and ß-
arrestin. Nothing is currently known about postendocytic
sorting of nephrin. Understanding the kinetics of binding
between nephrin and ß-arrestin may help to elucidate
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postendocytic itineraries of nephrin and their impact on
nephrin interactions with other GSD proteins.
CD2AP is another member of the GSD localized in the
cytoplasmic region juxtaposed to lipid raft membrane
domains. CD2AP interacts with podocin and nephrin and
anchors the proteins to the actin cytoskeleton stabilizing the
GSD [60]. CIN85/RukL is a closely related homologue of
CD2AP [61]. In intact podocytes CD2AP represses CIN85/
RukL expression by SUMOylation while the loss of CD2AP
removes repression and results in increased CIN85/RukL
abundance and leads to CIN85/RukL-mediated nephrin ubiq-
uitination and endocytosis [62, 63]. The model elucidating
why CIN85 behaves towards nephrin in a manner opposite to
CD2AP explains that unlike CD2AP, CIN85 does not contain
an actin-binding domain [62, 64]. It follows that absence of
CD2AP would impair nephrin partitioning to lipid rafts, in-
crease CIN85 abundance, and facilitate nephrin interaction
with CIN85. However, other investigators have shown that
CIN85 directly interacts with actin and together with CD2AP
bundles actin filaments and modulates podocyte migration
[65]. Moreover, CIN85 clusters Src, provides a platform for
actin related protein 2 (ARP2) and ARP3 (Arp2/3)-mediated
actin assembly, and plays a role in cell polarization and
motility (Fig. 1). The cell- and culture-dependent factors as
well as expression of different CIN85 splice variants may, at
least in part reconcile differences in CIN85 functions demon-
strated by different investigators. The ubiquitin ligase that
mediates nephrin ubiquitination has not been determined. c-
Cbl is the E3 enzyme originally identified as a binding partner
of CIN85 and mediates ubiquitination of many receptors [66].
It will be interesting to determine whether c-Cbl cooperates
with CIN85 and ubiquitinates nephrin in podocytes. After
recruiting c-Cbl to target membranes and receptors, CIN85
links the ubiquitinated receptor with endophilins A, which
facilitate formation of CCPs [67]. Future studies may eluci-
date whether similar mechanism takes place in podocytes
during nephrin endocytosis.
While Notch signaling regulates podocyte development, its
activation in the mature kidney alters FP architecture and indu-
ces proteinuria by a mechanism that involves nephrin endocy-
tosis in a dynamin-dependent and lipid raft-independent manner
[53]. At present, our understanding of the mechanisms and
purpose of nephrin endocytosis is incomplete. For example,
current data are insufficient to propose a unified model explain-
ing whether nephrin signaling is either attenuated or amplified
or both by nephrin endocytosis. Moreover, the relative contri-
bution of different mechanisms of nephrin endocytic remains
unknown. Understanding the mechanisms, function, and regu-
lation of nephrin endocytosis is critical for developing therapeu-
tic interventions to stabilize nephrin at the GSD.
Cadherins, the transmembrane adhesion receptors present
at the AJ of epithelial cells are important for establishing
cell-cell contact during embryonic development and
maturity in a variety of epithelia, including podocytes [68].
The intracellular domains of cadherin interact with a variety
of proteins that indirectly link cadherins with the contractile
actin cytoskeleton while the extracellular domains interact in
trans with cadherins on adjacent cells or in cis with cadherins
within the same membrane [69]. While the physiology of the
cis and trans interactions are not well understood, it has been
increasingly recognized that endocytic trafficking is critical
for regulation of trans interactions and control of adhesion
forces [70]. The endocytic trafficking of E-cadherin has been
studied extensively and the trafficking routes are cell-type and
condition-dependent. It would be interesting whether future
studies demonstrate the role of endocytic trafficking of cad-
herins in regulating adhesion forces at the GSD.
Membrane trafficking at Focal Contacts (FC)
Integrins are adhesion molecules that regulate cell attach-
ment and migration and inside-out and outside-in signaling
[71]. Integrins organize interactions between the cell and the
Fig. 1 Hypothetical model for nephrin regulation by CD2AP and
CIN85. Under physiological conditions, CD2AP represses CIN85 ex-
pression (a). CIN85 abundance increases after CD2AP depletion (b).
Hypothetical members of the network are identified by the question
mark. The double head orange arrows indicate protein–protein inter-
actions. The single head blue arrows indicate cellular effects. Arp2/3,
actin related protein 2 (ARP2) and ARP3; CD2AP, CD2-associated
protein2; CIN85, Cbl-interacting protein of 85 kDa; Cbl, Casitas B-
lineage Lymphoma; Ub, ubiquitin
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surrounding extracellular matrix (ECM) and influence the
composition of the ECM. The α- and ß-integrin subunits
form heterodimers and serve as receptors for a variety of
ECM molecules. Protein scaffolds organized by integrins at
the cell-ECM interface include focal adhesion kinases and
FERM (4.1 protein/ezrin/radixin/moezin) domain contain-
ing proteins, such as talin. Focal adhesion kinase (FAK) and
talin are present at the FP-GBM interface where FCs are
formed [38]. FCs contain mainly α3ß1 integrin heterodimers
that serve as receptors for laminin-10/11 and the importance
of integrins in podocyte physiology is illustrated by FP
effacement in α3-deficient mice [72]. Endocytosis and recy-
cling of integrins are recognized as important regulatory
mechanisms that control their function [71]. It was shown
that defined endocytic mechanisms and adaptors selectively
target-specific integrin heterodimers. ß-integrins contain
conserved endocytic motifs necessary for recruitment by
AP-2 and/or Disabled2 (Dab2) and for internalization via
CDE; although, some integrin heterodimers undergo CIE.
Integrin recycling occurs via the Rab4 and/or Rab11 route.
Redistribution of integrins by endocytic trafficking adjusts
their membrane abundance and spatially restricts their
localization to specific cellular regions, modulates Rho
GTPase signaling, influences how certain receptors inter-
act with their ligands, and controls deposition and remod-
eling of fibronectin in the ECM. Recent data demonstrate
that FP effacement is an integrin-dependent migratory
process [73]. Moreover, activation of FAK, which regu-
lates the spatial restriction of integrins to maintain cell
migrational polarity and localizes integrin signaling to the
cell front, also facilitates podocyte migration and FP
effacement [71, 74]. Future studies will establish the
specific role and regulation of integrin trafficking in
podocytes.
Membrane trafficking at the apical complex
The apical membrane of FPs facing Bowman’s space is
covered by the sialoglycoprotein containing glycocalyx that
maintains a negative surface charge of the podocyte urinary
surface. Podocalyxin is the most abundant member of the
sialomucin family present in the apical complex and functions
as an anti-adhesin. Charge repulsion depends on podocalyxin
abundance in the apical plasma membrane [75]. The correct
apical localization of podocalyxin depends on its interaction
with the Na+/H+ exchanger regulatory factor/ezrin/radixin/
moesin-binding phosphoprotein of 50 kDa (NHERF/EBP50)
that links podocalyxin to the actin cytoskeleton through ezrin
[76]. The interaction is mediated via the NHERF/EBP50
PSD-95/Dlg/ZO-1 (PDZ) domain and the PDZ interacting
domain of podocalyxin. PDZ-mediated protein interactions
promote rapid recycling of several transmembrane proteins.
Thus, it is expected that NHERF/EBP50 plays a role in the
dynamic regulation of the apical abundance of podocalyxin by
endocytic recycling. Podocalyxin expression is first noted
during the S-shaped body stage in the podocyte precursor
apical membrane and the protein is known to affect localiza-
tion and function of AJCs inMadin-Darby canine kidney cells
[75]. The podocalyxin interaction with NHEFR/EBP50 and
ezrin is disrupted in animal models of podocyte injury, and
podocalyxin uncoupling from the actin cytoskeleton corre-
lates with loss of FPs [77]. Podocalyxin expression is de-
creased in human glomerulopathies associated with NS [78].
Future studies are needed to elucidate the role of membrane
trafficking in the dynamic regulation of podocalyxin abun-
dance in the podocyte apical membrane.
Membrane trafficking and cytoskeletal dynamics
The function of mature podocytes is determined by static
and dynamic properties of the cytoskeleton. Tension-
bearing, vimentin-rich intermediate filaments and microtu-
bules present in the cell body and major and secondary
processes maintain cell shape and rigidity [28]. Moreover,
long actin filament bundles and perimembranous, short actin
networks determine the shape and function of FPs. The actin
cytoskeleton connects FPs with each other via the GSD. The
GSD actin network together with integral membrane protein
complexes and juxtaposed cytoplasmic protein adaptors and
effectors complete a highly dynamic multi-dimensional
scaffold transducing signals from the extra- and intracellular
environment in order to regulate glomerular filtration
(Fig. 2). Actin filaments in the FP contractile apparatus
change their length in response to signaling cues and regu-
late permeability of GFB [38]. Similar, a highly ordered
scaffold of membrane proteins, actin cytoskeleton, and cy-
toplasmic adaptors and effectors exists at FP sole plates and
regulates FCs between sole plates and the GBM [38]. Dur-
ing podocyte injury, actin filaments are replaced with a
dense actin network and this alteration in cytoskeletal orga-
nization leads to foot process effacement [79].
There is an inseparable reciprocity between the cytoskel-
eton and signaling. Actin and microtubule filament net-
works facilitate membrane trafficking during signal
transduction while cytoskeletal rearrangements and plasma
membrane deformities signal to modulate endocytic traf-
ficking. Actin regulates EE cargo sorting, membrane fission,
segregation, and stretching and disturbances of the actin
cytoskeleton lead to EE enlargement and sorting impairment
[80, 81]. The Arp2/3 complex mediates initiation of new
actin filaments and actin branching on preexisting filaments
and is activated by several proteins, including cortactin. In
podocytes, CD2AP colocalizes with Arp2/3 and cortactin
and regulates endosomal sorting and vesicle trafficking via
regulation of actin assembly [82]. Moreover, CD2AP asso-
ciates with the dynamic actin pool and co-localizes with AP-
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2, Rab5, Rab4, and participates in formation of MVBs [82,
83]. CD2AP interacts with podocin and nephrin and thus,
may function as a physical link, anchoring nephrin and
podocin to the actin cytoskeleton and controlling membrane
trafficking of nephrin and/or podocin through regulation of
actin assembly and vesicle sorting. It is interesting whether
future studies will demonstrate a direct role of CD2AP in
nephrin and/or podocin membrane trafficking.
Fig. 2 Network of physical and functional associations underlying
cross-talk between membrane trafficking, cytoskeletal dynamics, and
signaling in podocyte FP. Membrane bridging and juxtaposed cyto-
plasmic proteins (blue), membrane trafficking adaptors (green), cyto-
skeletal proteins (yellow), and signaling molecules (red) orchestrate
membrane trafficking and intracellular signaling. Hypothetical mem-
bers of the network are identified by the question mark. The double
head orange arrows indicate protein-protein interactions. The single
head blue arrows indicate cellular effects. AP-2, assembly polypeptide-
2 complex; Arp2/3, actin related protein 2 (ARP2) and ARP3; CaMK,
calcium/calmodulin-dependent protein kinase; CART, cytoskeleton
associated recycling or transport complex (Hrs/α-actinin-4/myosin
V); CCV, clathrin-coated vesicle; CD2AP, CD2-associated protein2;
ERC, early recycling complex; MAGI, membrane-associated guany-
late kinase inverted; NHERF, Na+/H+ exchanger regulatory factor;
PI3K, phosphoinositide 3-OH kinase; PIP(5), phosphatidylinositol 4-
phosphate 5-kinase; PKC, protein kinase C; Rab, Ras-associated bind-
ing; Rac1, Ras-related C3 botulinum toxin substrate 1; RhoA, ras
homolog gene family, member A; RTK, receptor tyrosine kinase;
TRPC, transient receptor potential canonical channel; CA, contractile
apparatus; FC, focal contact; GSD, glomerular slit diaphragm; PM,
plasma membrane
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Several other factors connect actin dynamics and membrane
trafficking at the GSD and FCs. α-actinin-4 cross-links actin
and provides structural stability for cell-cell contact by con-
necting actin filaments with the cell adhesion receptors,α and ß
integrins, and with the TJ and GSD protein, membrane-
associated guanylate kinase inverted (MAGI)-1 [84]. At the
GSD, α-actinin-4 interacts directly with nephrin and forms a
multiprotein scaffold with other integral membrane and cyto-
plasmic proteins [38]. Direct binding between MAGI-1 and
megalin—both members of the multi-protein network orga-
nized by α-actinin-4 was proposed to play a role in network
assembly in podocytes. Megalin is a member of the LDL
receptor family and an endocytic adaptor and facilitates endo-
cytosis of exogenous α-galactosidase A in podocytes from
patients with Fabry disease [85]. These data demonstrate that
megalin may facilitate endocytosis in podocytes. As a member
of the CART (cytoskeleton-associated recycling or transport):
an Hrs/actinin-4/BERP/myosin V, α-actinin-4 mediates con-
stitutive recycling of the transmembrane receptors via the rapid
recycling route in an actin-dependent manner [86]. Practically
nothing is known about the role of α-actinin-4 or other mem-
bers of the CART complex in trafficking of multi-protein
scaffolds at the GSD or FCs. α-actinin-4 gene mutations are
associated with focal segmental glomerulosclerosis (FSGS) [87].
Even though the mechanisms are far from being understood,
cytoplasmic sequestration of transcription factors caused by
α-actinin-4 gene mutations suggests that α-actinin-4 plays an
important role in membrane trafficking [87]. Future studies will
determine whether α-actinin-4 controls transcriptional responses
in podocytes via actin-dependent membrane trafficking events.
The Rho family of small GTPases: Ras homolog gene
family, member A (RhoA), Cdc42, and Ras-related C3 botuli-
num toxin substrate 1 (Rac1) regulate many aspects of phys-
iological and pathological cell behaviors, including actin
dynamics and cell motility and migration [88]. For example,
rapid cytoskeletal rearrangements mediated by actin assembly
and actin filament length changes in response to external
mechanical stress are mediated by Rho signaling. In podo-
cytes, RhoA signaling is regulated by synaptopodin, a member
of the multi-protein scaffold at the interface between FP sole
plates and theGBM and leads to formation of actin stress fibers
[89]. Nothing is currently known about the regulation of RhoA
trafficking in podocytes. In endothelial cells of sprouting ves-
sels, RhoA translocates from the cell-cell junction to the cell
leading edge in Rab13-positive endocytic vesicles containing
several factors necessary for Rho activation and downstream
signaling, including α-actinin-4 [90]. Rab13 also facilitates
assembly of the TJ and cell-cell junctions suggesting that
junctional proteins may play a role in cell migration [91].
Similar to RhoA, activation and trafficking of Rac1 occurs in
Rab5-positive endocytic vesicles and is necessary for Rac1
signaling [92]. Whether RhoA signaling is regulated by mem-
brane trafficking in podocytes remains to be determined.
Rho GTPases are activated by calcium (Ca+2) influx
generated by transient receptor potential (TRP) canonical
channels in cellular microdomains associated with recruit-
ment of either RhoA or Rac1 [93, 94]. In podocytes and
fibroblasts, TRPC5-mediated Ca+2 influx activates Rac1
and promotes cell migration [95]. By contrast, TRPC6-
mediated Ca+2 influx activates RhoA and inhibits cell mi-
gration. Ca+2 ions are critically important for signaling in
podocytes by a variety of mechanisms and mutations in the
TRPC6 gene are associated with FSGS [94]. Adjusting
channel abundance at the plasma membrane—because these
channels are constitutively active at physiological mem-
brane potentials—regulates Ca+2 influx [93, 96, 97]. Other
mechanisms, including myosin light chain kinase and calci-
um/calmodulin-dependent protein kinase (CaMK) are also
involved in the channel activation process and may be cell-
type-specific [98, 99]. Membrane trafficking is critical for
Ca+2 influx in cells, such as podocytes where the influx
depends on the plasma membrane abundance of TRPC5
and TRPC6. In fibroblasts, translocation of active TRPC5
from a submembranous compartment to the plasma mem-
brane is induced by EGF and requires Rac1, PI3K, and
phosphatidylinositol 4-phosphate 5-kinase alpha (PIP
(5)Kα) [100]. Channel translocation increases Ca+2 influx
and initiates morphological changes in cells in response to
stimuli. Translocation of TRPC5 and/or TRPC6 to the plas-
ma membrane likely occurs in Rab11-positive recycling
vesicles associated with ERC and requires NHERF2 [101].
TRPC6 localizes to the GSD and together with podocin and
the juxtaposed actin cytoskeleton is hypothesized to func-
tion as a sensor of osmotically and mechanically induced
membrane stretch [102]. Myosin V is a progressive, non-
conventional motor and a mechanosensor that transports
cargo in Rab11-positive recycling vesicles on actin fila-
ments to the plasma membrane [103]. The myosin V motor
activity requires CaMK and a tight control of Ca+2 concen-
tration in microdomains referred to as regulated motor units
[104, 105]. Based on the information, it is reasonable to
predict that myosin V may transport TRPC5 and/or TRPC6
in Rab11-positive recycling vesicles and that the channels
may regulate myosin V function by controlling Ca+2 influx
in myosin V-based-regulated motor units. Future studies
will need to examine the prediction.
Nephrin and CD2AP interact with the p85 regulatory
subunit of the phosphoinositide 3-OH kinase (PI3K) and
recruit PI3K to the plasma membrane [106]. PI3K plays an
essential role in a multi-level regulation of receptor tyrosine
kinases (RTK) trafficking, including regulation of membrane
lipid composition, release of CCVs, and the Rab5 recruitment
and switch off [107]. These functions are critical to RTK
signaling. The interactions of PI3K with nephrin, CD2AP,
and several other GSD protein networks indicate an important
role of PI3K regulated membrane trafficking in several aspects
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of GSD function. For example, a recent study demonstrated
that nephrin mediates actin reorganization in podocytes via
PI3K [108]. More studies examining cross-talk between actin
dynamics and membrane trafficking at the GDSmay elucidate
how cytoskeletal remodeling affects membrane trafficking
and signaling in podocytes and how mutations in proteins
controlling cross-talk lead to cytoskeletal rearrangements, FP
effacement, and proteinuria.
Membrane trafficking and podocyte injury
The pervasiveness of membrane trafficking in virtually ev-
ery event of cell regulation predicts that alterations of endo-
cytic machinery and intracellular sorting should play an
important role in human pathology at large. Indeed, the
pathogenesis of many diseases can be traced back to dis-
rupted membrane trafficking [1]. Below is a brief review of
studies, not included in the previous sections that illustrate
the impact of abnormal membrane trafficking on podocyte
injury and glomerular disease. Plasma obtained from
patients with NS reversibly displaces nephrin, podocin,
and CD2AP from the cell surface into the cytoplasm in
cultured human podocytes [109]. While nephrotic plasma
may be deficient in factor(s) critical for cell polarization and
podocyte function, as demonstrated by the effects of the
podocyte-specific loss of Cdc42 [31, 32], it is also plausible
that nephrotic plasma may contain abnormal factor(s) that
alter membrane trafficking in podocytes. Such factor(s)
could be generated by abnormal cell signaling in injured
podocytes, increased mechanical stress (hyperfiltration-me-
diated injury), or abnormal podocyte adhesion forces [110,
111]. Examples of factors likely affecting membrane traf-
ficking in podocytes are discussed below.
Membrane trafficking is critically involved in the execution
of epithelial-mesenchymal transformation (EMT) that accom-
panies glomerular fibrosis, including TGF-ß induced EMT in
diabetic nephropathy [112]. Moreover, certain mutations in the
TRPC6 gene affect channel trafficking and prevent its insertion
in the GSD membrane leading to abnormal Ca+2 homeostasis
and signaling, podocyte injury and FSGS [113]. By contrast,
activation of wild type TRPC6 or activating mutations in the
channel also lead to podocyte injury and proteinuria indicating
that control of TRPC6 trafficking and cell membrane abun-
dance are critical for podocyte function [114]. Parenthetically,
adjusting channel abundance in the GSD by regulating its
endocytic trafficking may serve as a potential therapeutic
approach to normalize TRPC6 signaling. Whether inflamma-
torymediators affect GSD integrity bymodulating endocytosis
and recycling of junctional proteins, as documented in intesti-
nal epithelial cells, remains unknown [115].
Renin-angiotensin system (RAS) activation, as seen in glo-
merular hyperfiltration is an important cause of podocyte inju-
ry and proteinuria [116]. In persistent RAS activation,
angiotensin II leads to rearrangement of the actin cytoskeleton
resulting in a podocyte phenotype switch to migratory by
mechanisms involving activation of Rac-1 and FERM pro-
teins, downregulation of 〈-actinin-4, and reduction of FC num-
ber [117]. Moreover, angiotensin II decreases abundance of
GSD proteins and induces nephrin dephosphorylation by the
caveolin-dependent mechanism, suggesting a role of CIE in
this process [118]. The synthetic erythropoietin, darbepoetin
protects podocytes from injury by a mechanism that involves
restoration of nephrin expression in the GSD [119]. It would be
interesting to determine whether darbepoetin regulates mem-
brane trafficking of nephrin or other GSD proteins. Elevated
levels of serum soluble urokinase receptor (suPAR), observed
in patients with FSGS activates ß3 integrin and lead to FP
effacement, glomerulopathy, and proteinuria [120]. It can be
predicted that podocyte injury caused by suPAR via ß3 integrin
activation involves altered podocyte adhesion to the GBM
mediated by altered membrane trafficking.
Conclusions and perspectives
Membrane trafficking is the master regulator of virtually every
cellular function. Although little evidence exists, studies in
other organ systems strongly indicate that the versatility of
membrane trafficking allows dynamic regulation of elaborate
protein scaffolds and signaling cascades during podocyte de-
velopment, differentiation, and maintenance of manure podo-
cytes. Moreover altered membrane trafficking may be the
cause and/or the result of podocyte injury. Proteinuria is an
important health problem associated with diseases affecting the
GFB and diagnostic tools and treatment options are limited and
not optimal at best. Biomedical and pharmaceutical applica-
tions of nanotechnology exploiting endocytosis and transcyto-
sis for targeted delivery of diagnostics and therapeutics have
been gaining momentum in other medical fields [121]. Cul-
tured podocytes internalize proteins via endocytosis and this
trafficking route has been explored as a method for drug
delivery to injured podocytes [122, 123]. Future studies re-
vealing the role, mechanisms, and regulation of membrane
trafficking in podocyte health and disease may help to design
diagnostic approaches and targeted treatments for proteinuria.
Since protein trafficking is cell- and polarization-dependent,
one of the future challenges would be to study membrane
trafficking in human podocytes.
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